Ausun Pharm released its first-quarter performance, with a net profit attributable to the parent company of 119 million yuan, a year-on-year increase of 5.97%
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, Ausun Pharm disclosed its first-quarter report for 2025, reporting revenue of 307 million yuan, a year-on-year increase of 1.90%; net profit attributable to the parent company of 119 million yuan, a year-on-year increase of 5.97%; and net profit excluding non-recurring gains and losses of 112 million yuan, a year-on-year increase of 2.81%. Basic earnings per share are 0.14 yuan
According to the Zhitong Finance APP, Ausun Pharm (603229.SH) disclosed its first-quarter report for 2025. During the reporting period, the company achieved revenue of 307 million yuan, a year-on-year increase of 1.90%; net profit attributable to the parent company was 119 million yuan, a year-on-year increase of 5.97%; and net profit excluding non-recurring gains and losses was 112 million yuan, a year-on-year increase of 2.81%. Basic earnings per share were 0.14 yuan